I'm not too keen on trying to read between the lines on these...

I'm not too keen on trying to read between the lines on these kind of things. What I know is that clinical studies take time (and they shouldn't be rushed). The FDA approval welcome through if successful use of the products continues, but it will take time. Sales in China (and other regions) will come through also. If AVH has to raise capital to get through to these significant milestones then so be it. The Board must make that decision if that time comes. If a CR does happen it looks like it will be done at a higher price than the last one. And if the funds are used to get to the point where trial results are received, approvals are obtained and sales increase then I'll be a happy shareholder.